These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27742352)

  • 21. Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications.
    Desai RJ; Good MM; San-Juan-Rodriguez A; Henriksen A; Cunningham F; Hernandez I; Good CB
    JAMA Netw Open; 2019 Sep; 2(9):e1910626. PubMed ID: 31483473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
    Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-treatment with varenicline is a cost-effective aid for smoking cessation.
    Kautiainen K; Ekroos H; Puhakka M; Liira H; Laine J; Linden K; Hahl J
    J Med Econ; 2017 Mar; 20(3):246-252. PubMed ID: 27754739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDA speeds smoking cessation drug review.
    Kuehn BM
    JAMA; 2006 Feb; 295(6):614. PubMed ID: 16467225
    [No Abstract]   [Full Text] [Related]  

  • 25. Utilization management for smoking cessation pharmacotherapy: varenicline rejected claims analysis.
    Zeng F; Chen CI; Mastey V; Zou KH; Harnett J; Patel BV
    Am J Manag Care; 2010 Sep; 16(9):667-74. PubMed ID: 20873954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smokers and Postcessation Weight Gain After Acute Coronary Syndrome.
    Dehghani P; Habib B; Windle SB; Roy N; Old W; Grondin FR; Bata I; Iskander A; Lauzon C; Srivastava N; Clarke A; Cassavar D; Dion D; Haught H; Mehta SR; Baril JF; Lambert C; Madan M; Abramson BL; Eisenberg MJ
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28420644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking cessation-recent advances.
    McNeil JJ; Piccenna L; Ioannides-Demos LL
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):359-67. PubMed ID: 20602163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Varenicline in smoking cessation.
    Tonstad S; Rollema H
    Expert Rev Respir Med; 2010 Jun; 4(3):291-9. PubMed ID: 20524911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychosis Induced by Varenicline in a Patient With No Psychiatric History.
    Tuman TC
    Prim Care Companion CNS Disord; 2017 Aug; 19(4):. PubMed ID: 28841273
    [No Abstract]   [Full Text] [Related]  

  • 30. Varenicline gets stronger warnings about psychiatric problems, vehicle crashes.
    Kuehn BM
    JAMA; 2009 Aug; 302(8):834. PubMed ID: 19706852
    [No Abstract]   [Full Text] [Related]  

  • 31. Taking varenicline for smoking cessation: A rare cause of pulmonary thromboembolism with infarction.
    Lee SH; Yun SJ; Ryu S; Choi SW; Kim HJ; Kang TK; Oh SC; Cho SJ
    Am J Emerg Med; 2017 Jul; 35(7):1037.e3-1037.e6. PubMed ID: 28268112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and safety of varenicline as an aid to smoking cessation: results of an inter-Asian observational study in real-world clinical practice.
    Wang C; Cho B; Xiao D; Wajsbrot D; Park PW
    Int J Clin Pract; 2013 May; 67(5):469-76. PubMed ID: 23574106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sustainable efficacy of oral varenicline for smoking cessation].
    Onizawa S; Taniguchi H; Nozu T; Asano A; Katsura H; Saiki K; Kiguchi T; Hasegawa M; Nagai A
    Nihon Kokyuki Gakkai Zasshi; 2010 Nov; 48(11):791-6. PubMed ID: 21141055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Prolonged Exposure to Varenicline in Adult Rats: Haematological, Biochemical and Anatomopathological Studies.
    Zaccarelli-Magalhães J; Moreira N; Sandini TM; de Abreu GR; Sánchez-Sarmiento AM; Ricci EL; Fukushima AR; de Souza Spinosa H
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):305-309. PubMed ID: 28944993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.
    Toh S; Baker MA; Brown JS; Kornegay C; Platt R;
    JAMA Intern Med; 2013 May; 173(9):817-9. PubMed ID: 23529063
    [No Abstract]   [Full Text] [Related]  

  • 36. Increasing the dose of varenicline in patients who do not respond to the standard dose.
    Jiménez-Ruiz CA; Barrios M; Peña S; Cicero A; Mayayo M; Cristóbal M; Perera L
    Mayo Clin Proc; 2013 Dec; 88(12):1443-5. PubMed ID: 24290118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smoking cessation: an overview of treatment options with a focus on varenicline.
    Stack NM
    Pharmacotherapy; 2007 Nov; 27(11):1550-7. PubMed ID: 17963463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey.
    Enger C; Younus M; Petronis KR; Mo J; Gately R; Seeger JD
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):705-15. PubMed ID: 23349095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of varenicline on Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio in healthy smokers and nonsmokers.
    Ari H; Ari S; Coşar S; Celiloğlu N; Aktaş İ; Camci S; Doğanay K; Tütüncü A; Melek M
    Cardiol J; 2015; 22(5):551-6. PubMed ID: 26100824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking cessation improves cardiometabolic risk in overweight and obese subjects treated with varenicline and dietary counseling.
    Heggen E; Svendsen M; Tonstad S
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):335-341. PubMed ID: 28216282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.